Skip to main content
Caplight Logo









Capital Cell

Capital Cell

Overview

Capital Cell is a European equity crowdfunding platform focused on biotechnology and life science projects.

Year Founded

2015

Portfolio Companies

48

Investments

Capital Cell investments
CompanyDateStageLead
Axoltis PharmaDec 2025Series ACo-investor
Hemerion TherapeuticsMay 2025Series ACo-investor
VeriGraftMar 2025CrowdfundingCo-investor
Ability PharmaceuticalsMar 2024Early FundingCo-investor
EVerZomOct 2025Series ACo-investor
Book a demo to see all 48 portfolio companies

For institutional investors. Book with your work email.

Key People

Daniel Oliver

Director

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Capital Cell based?

Capital Cell is headquartered in Barcelona, Spain.

When was Capital Cell founded?

Capital Cell was founded in 2015.

How many portfolio companies does Capital Cell have?

Capital Cell has 48 portfolio companies in Caplight's dataset.

What are some companies in Capital Cell's portfolio?

Portfolio companies visible on Caplight include Axoltis Pharma, Hemerion Therapeutics, VeriGraft, Ability Pharmaceuticals, EVerZom.

What was Capital Cell's most recent investment shown here?

Capital Cell's most recent investment in this portfolio sample was in Axoltis Pharma in 2025.

What sectors does Capital Cell focus on?

Capital Cell focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech, Enterprise Software, Frontier & Industrial Tech, Enterprise Software, AI, Data & Cloud Infrastructure, Consumer & Commerce, Frontier & Industrial Tech, Consumer & Commerce, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Enterprise Software.

What company stages does Capital Cell focus on?

Capital Cell typically invests at the Early stage.

Firmographic Details

HeadquartersBarcelona
Year Founded2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?